Chromadex Corp
Change company Symbol lookup
Select an option...
CDXC Chromadex Corp
EPRT Essential Properties Realty Trust Inc
CRIS Curis Inc
PIXY ShiftPixy Inc
RVLP RVL Pharmaceuticals PLC
NAUT Nautilus Biotechnology Inc
BOF BranchOut Food Inc
SPRC Scisparc Ltd
NRSN Neurosense Therapeutics Ltd
ACNT Ascent Industries Co
Go

Health Care : Life Sciences Tools & Services | Small Cap Blend
Company profile

Chromadex Corp. is a bioscience company, which is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain its ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. It provides Niagen in ingredient form to its strategic partners. It provides Niagen in ingredient form to its strategic partners. It also offers Immulina, which is a spirulina extract. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Postmarket

Last Trade
Delayed
$1.41
-0.05 (-3.42%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$1.46
Day's Change
0.05 (3.55%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
1.48
Day's Low
1.39
Volume
(Heavy Day)
Volume:
210,570

10-day average volume:
87,533
210,570

Company Profile

Chromadex Corp. is a bioscience company, which is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain its ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. It provides Niagen in ingredient form to its strategic partners. It provides Niagen in ingredient form to its strategic partners. It also offers Immulina, which is a spirulina extract. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
1.31x
Price/Book (MRQ)
3.89x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

September 2023
Current Month
1.3M
Previous Month
1.4M
Percent of Float
2.96%
Days to Cover
11.1983 Days

Share Information

CDXC is in a share class of common stock
Float
44.0M
Shares Outstanding
75.0M
Institutions Holding Shares
63
15.31%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Frank L. Jaksch
  • Robert N. FriedPres.
  • Brianna GerberCFO
  • Steven D. Rubin
  • Ann Cohen

Address

Insider Trading

During the most recent quarter, 3M shares were bought in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.